AI company Zebra Medical Vision has scored another approval from the FDA, this time for its AI alert that can help diagnose pneumothoraces based on chest X-rays.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh